Suchergebnisse - "Rahman, Omar"

PubPharm (22)

1

Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms : from Bench to Bedside

enthalten in: Current oncology reports | 2022

von de Sousa, M. | Gervaso, L. | Meneses-Medina, M. | +3

2

Safety issues with the ALK inhibitors in the treatment of NSCLC : A systematic review

enthalten in: Critical reviews in oncology/hematology | 2019

von Kassem, L. | Shohdy, K. | Lasheen, S. | +3

3

Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma

enthalten in: Molecular cancer | 2018

von Kashyap, M. | Abdel-Rahman, O.

4

Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma : a retrospective cohort study

enthalten in: Expert review of gastroenterology & hepatology | 2018

von Nada, Y. | Rashad, N. | Eissa, M. | +6

5

The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma

enthalten in: Canadian journal of gastroenterology & hepatology | 2018

von Abdel-Rahman, O. | Cheung, W.

6

Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Breast cancer (Tokyo, Japan) | 2018

von Kassem, L. | Shohdy, K. | Lasheen, S. | +2

7

Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2017

von Lasheen, S. | Shohdy, K. | Kassem, L. | +1

8

Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib : a systematic-review and meta-analysis of the impact on survival

enthalten in: Expert review of gastroenterology & hepatology | 2017

von Abdel-Rahman, O. | Lamarca, A.

9

Targeting the MEK signaling pathway in non-small cell lung cancer (NSCLC) patients with RAS aberrations

enthalten in: Therapeutic advances in respiratory disease | 2016

von Abdel-Rahman, O.

10

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.